About Us
BOARD OF DIRECTORS
Chairman and CEO

Don Hayden brings broad pharmaceutical and biotech experience and insight to the WindMIL Board. Mr. Hayden had a highly successful 25-year career with the Bristol-Myers Squibb Company and continues to hold key roles at a number of entrepreneurial pharmaceutical and biotech companies. At Bristol-Myers Squibb, he served as president of Global Pharmaceuticals; executive vice president […]

Brian Dovey has been a partner of Domain Associates since 1988, where he has led investments, and he has served on the board of directors of more than 35 private and public companies. Prior to Domain, Mr. Dovey spent six years at Rorer Group (now part of Sanofi-Aventis). As president of Rorer from 1986 to […]

Allan Fox is the founding partner of FOXKISER, a nationally recognized firm specializing in biomedical research and development, law and public policy. He has created and built numerous ventures in both the public and private sectors. While in the public sector, he served as Chief of Staff and Chief Legislative Assistant to U.S. Senator Jacob […]

Anna French, PhD, is an associate at Qiming Ventures Partners, based in Boston. Prior to joining Qiming Ventures in July 2017, Dr. French was a management consultant at the Boston Consulting Group (BCG) where she advised top 10 global biopharma companies on their strategy and operations. Prior to BCG, Dr. French led a global industry-academic […]

Mr. McDade is co-founder and Managing Partner of Qiming Venture Partners US, which was started in January 2017. Prior to Qiming, Mr. McDade was Executive Vice President, Chief Operating Officer at UCB. He led UCB’s worldwide Geographic Operations, Established Brands, Technical Operations and Business Development while based in Brussels. He joined UCB’s Executive Committee in […]

Howard Soule, PhD, has served as the executive vice president and chief science officer of the Prostate Cancer Foundation since 1997. In this capacity, Dr. Soule coordinates global academic, government and biopharmaceutical sector research activity and is responsible for the implementation of Prostate Cancer Foundation global research strategies. He previously served as managing director of […]